Deciphex

Deciphex

診断と前臨床安全性評価のためのデジタル病理基盤

概要

Deciphex builds two digital pathology platforms: Diagnexia, which connects subspecialty pathologists for rapid diagnostics and backlog reduction, and Patholytix, which accelerates drug development through preclinical safety assessment. Based at Dublin City University's Alpha campus, it manages a network of more than 250 subspecialty pathologists and processes roughly 97,000 cases a year. The venture debt funds US expansion. Headquartered in Dublin.

資金調達

ラウンド 金額 発表日 投資家
Debt 会員限定 会員限定 投資家 1社

MEMBERS ONLY

調達金額・発表日・投資家名は会員限定です。

ログインして閲覧

会員・法人プランについて